A clinically validated AI framework for kidney cancer detection and characterization

20250 citationsJournal Articlegold Open Access

Authors

Bohdan Petryshak · Tallinn University

Mikhail Iljin · Tallinn University

Alina Denissova · Tallinn University

Joonas Ariva · Software Technology and Applications Competence Center

Toomas Häide · Tallinn University

Veljo Lasn · Tallinn University

M. Reim ·

Abstract

To the best of our knowledge, BMVision is the first clinically validated commercial artificial intelligence tool for kidney cancer detection and characterization. By improving diagnostic accuracy and reporting efficiency, it has the potential to enhance patient care and help radiologists meet the growing demand for high-quality cancer diagnostics.

Topics & Keywords

Renal cell carcinoma treatment AI in cancer detection Radiomics and Machine Learning in Medical Imaging

Publication Details

Published in: Communications Medicine

Volume 5, Issue 1, pp. 541-541

DOI: 10.1038/s43856-025-01264-0

Field-Weighted Citation Impact: 0.00

Command Palette

A clinically validated AI framework for kidney cancer detection and characterization

Authors

Abstract

Topics & Keywords

Publication Details